Protocols

Soon-Shiong blasts back at “maliciously false” STAT story; ImmunoMet raises $5M

→ Badly wounded by a report from STAT that he essentially funneled revenue to his company through a charitable gift to the University of Utah, Patrick Soon-Shiong is firing back in the LA Times, saying the story is “maliciously false.” He adds that he gave the money to the university out of a “desire to make this knowledge available to scientists throughout the world.” The report carved out a big chunk of NantHealth’s share price $NH earlier in the week. Soon-Shiong is the second largest shareholder in the company that owns the LA Times.

→ Houston-based ImmunoMet Therapeutics raised $5 million in a Series B financing with participation from Intervest, SL Investment, NHN Investment along with the Series A investors Mirae Asset Venture Investments, GNTech and Dr. Sung-wuk Kim, founder, chairman and CEO of ImmunoMet.

→ The microcap penny stock biotech Heat Biologics $HBTX has come up with a deal to buy Austin-based Pelican Therapeutics, agreeing to pay up to $500,000 for an 80% share of the company.


The best place to read Endpoints News? In your inbox.

Full-text daily reports for those who discover, develop, and market drugs. Join 19,000+ biopharma pros who read Endpoints News by email every day.

Free Subscription

BioNJ CEO Summit 2017